Filing Details
- Accession Number:
- 0001628280-24-049079
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-25 07:28:56
- Reporting Period:
- 2024-11-22
- Accepted Time:
- 2024-11-25 07:28:56
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1386570 | Chromadex Corp. | CDXC | Medicinal Chemicals & Botanical Products (2833) | 262940963 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1834681 | Ozan Pamir | 10900 Wilshire Blvd. Suite 600 Los Angeles CA 90024 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-11-22 | 2,907 | $7.36 | 2,907 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The weighted average purchase price for the transaction reported was $7.36, and the range of prices were between $7.345 and $7.36, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range above will be provided.